Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer.

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.

After a devastating diagnosis, Simone I. Smith and husband LL COOL J sought answers and a new mission to help others

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on Thursday ahead of a major medical meeting.

Women with dense breasts would indeed benefit from additional scans on top of their standard mammograms, the clinical trial has now concluded. Extra imaging tests could more than triple breast cancer detection among women with dense breasts, researchers reported May 21 in the journal The Lancet.

Plus: Trump’s Surgeon General nominee and MAHA; and what Israeli officials are privately saying about starvation in Gaza.

Colorectal cancer is becoming more common among younger adults. Screening guidelines have evolved to reflect that.

Yearly cancer deaths linked to alcohol have doubled in the United States over the last three decades, rising from just under 12,000 a year in 1990 to more than 23,000 a year in 2021, new research finds.